Literature DB >> 14593475

Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice.

Carola Leipner1, Katja Grün, Ilka Schneider, Brigitte Glück, Holger H Sigusch, Axel Stelzner.   

Abstract

Coxsackievirus B3 (CVB3) infections are the most frequent causes of human myocarditis, often resulting in chronic stages characterized by fibrosis and loss of function. This disease is called dilated cardiomyopathy (DCM). Persistent virus in the myocardium may lead to chronic activation of fibroblasts, and subsequently, to fibrosis of the myocardium. Studies with immunodeficient mice have shown that certain defects of the immune system retard the rate at which virus is eliminated from the heart, thus leading to viral persistence. Therefore, we followed the immune response of two immunocompetent mouse strains (C57BL/6 and Balb/c) to CVB3 infection. These two strains have been reported to develop different immune responses to infections and we expected a similar reaction to viral infections as well. The two mouse strains recovered completely from CVB3 infection and expressed identical levels of cytokine mRNA in the heart. However, the virus in heart tissue decreased more slowly in Balb/c than in C57BL/6 mice. This was accompanied by a strong virus-specific IgG and weak IgM response in the C57BL/6 mice, in comparison to the Balb/c mice. We conclude, therefore, that viral-specific IgG is of importance for CVB3 elimination from infected hearts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593475     DOI: 10.1007/s00430-003-0199-5

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  32 in total

1.  In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease.

Authors:  R Kandolf; D Ameis; P Kirschner; A Canu; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

2.  The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.

Authors:  C Leipner; K Grün; M Borchers; A Stelzner
Journal:  Herz       Date:  2000-05       Impact factor: 1.443

3.  Quantitation of enteroviral RNA by competitive polymerase chain reaction.

Authors:  T A Martino; M J Sole; L Z Penn; C C Liew; P Liu
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

Review 4.  Immunology taught by viruses.

Authors:  R M Zinkernagel
Journal:  Science       Date:  1996-01-12       Impact factor: 47.728

5.  Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice.

Authors:  L J Wolfgram; K W Beisel; A Herskowitz; N R Rose
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

Review 6.  Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis.

Authors:  S Tracy; V Wiegand; B McManus; C Gauntt; M Pallansch; M Beck; N Chapman
Journal:  J Am Coll Cardiol       Date:  1990-06       Impact factor: 24.094

7.  Persistent expression of cytokine in the chronic stage of viral myocarditis in mice.

Authors:  T Shioi; A Matsumori; S Sasayama
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

8.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.

Authors:  A Henke; S Huber; A Stelzner; J L Whitton
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction.

Authors:  L M Weiss; L A Movahed; M E Billingham; M L Cleary
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

10.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.

Authors:  K Klingel; C Hohenadl; A Canu; M Albrecht; M Seemann; G Mall; R Kandolf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

View more
  8 in total

Review 1.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

Review 2.  Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection.

Authors:  Toshitaka Yajima
Journal:  Future Microbiol       Date:  2011-05       Impact factor: 3.165

3.  Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.

Authors:  Kohei Tatsumi; Clare M Schmedes; E Reaves Houston; Emily Butler; Nigel Mackman; Silvio Antoniak
Journal:  Cell Immunol       Date:  2019-07-03       Impact factor: 4.868

4.  Effect of AMP-activated protein kinase activation on cardiac fibroblast proliferation induced by coxsackievirus B3.

Authors:  Shengyang Jiang; Shunli Tian; Xueming Wu; Yijia Tao; Donglin Jiang
Journal:  Exp Ther Med       Date:  2016-03-18       Impact factor: 2.447

Review 5.  Coxsackievirus B3-Its Potential as an Oncolytic Virus.

Authors:  Anja Geisler; Ahmet Hazini; Lisanne Heimann; Jens Kurreck; Henry Fechner
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

6.  Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis.

Authors:  Xiaoxiao Liu; Minghui Li; Zhiwei Chen; Yong Yu; Hui Shi; Ying Yu; Yucheng Wang; Ruizhen Chen; Junbo Ge
Journal:  Basic Res Cardiol       Date:  2022-08-23       Impact factor: 12.416

7.  Exploration of Analgesia with Tramadol in the Coxsackievirus B3 Myocarditis Mouse Model.

Authors:  Sandra Pinkert; Meike Kespohl; Nicolas Kelm; Ziya Kaya; Arnd Heuser; Karin Klingel; Antje Beling
Journal:  Viruses       Date:  2021-06-24       Impact factor: 5.048

8.  Non-invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo.

Authors:  Matthijs Raaben; Henk-Jan Prins; Anton C Martens; Peter J M Rottier; Cornelis A M De Haan
Journal:  Cell Microbiol       Date:  2009-02-10       Impact factor: 3.715

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.